Prejunctional actions of K+ channel blockers in rat vas deferens
- PMID: 8991803
- DOI: 10.1016/0014-2999(95)00495-5
Prejunctional actions of K+ channel blockers in rat vas deferens
Abstract
In studies of isometric contractions in prostatic portions of rat vas deferens evoked by single pulse electrical stimulation, the K+ channel blockers 4-aminopyridine, tetraethylammonium and charybdotoxin, but not apamin, significantly reduced the prejunctional inhibitory potency and the maximum inhibitory effect of the alpha 2-adrenoceptor agonist xylazine. The protein kinase C activator phorbol dibutyrate had similar effects to 4-aminopyridine against xylazine. However, 4-aminopyridine, tetraethylammonium, charybdotoxin and phorbol dibutyrate, but not apamin, significantly increased the magnitude of the isometric contraction to a single stimulus. 4-Aminopyridine and phorbol dibutyrate significantly reduced, while tetraethylammonium did not affect, isometric contractions to noradrenaline, and 4-aminopyridine failed to affect contractions to alpha,beta-methylene-ATP, so that the effects of these agents on the isometric contraction to a single stimulus were presumably by a prejunctional action. The Ca2+ entry facilitator Bay K 8644 (1,4-dihydro-2,6-dimethyl-5-nitro-4-[2-(trifluoromethyl)-phenyl]-3-pyrid ine carboxylic acid methylester) increased stimulation-evoked contractions by a postjunctional action and reduced the inhibitory effects of xylazine. When the isometric contraction following 4-aminopyridine was reduced by decreasing the stimulation voltage or by reducing the Ca2+ concentration from 2.5 to 0.9 mM, 4-aminopyridine significantly reduced the potency of xylazine. However, tetraethylammonium and Bay K 8644 failed to affect the inhibitory potency of xylazine in low Ca2+. It is concluded that the K+ channel blocker 4-aminopyridine reduces the prejunctional inhibitory potency of xylazine, and this action is independent of increased neurotransmitter release. These results suggest that prejunctional alpha 2-adrenoceptor-mediated inhibition in rat vas deferens involves K+ channels sensitive to block by 4-aminopyridine.
Similar articles
-
Modulation of adrenergic responses of human vas deferens by K+ channel inhibitors.Urology. 2010 Dec;76(6):1518.e7-12. doi: 10.1016/j.urology.2010.07.475. Epub 2010 Oct 8. Urology. 2010. PMID: 20932556
-
Potassium channel inhibitors attenuate neuromodulatory effects of atrial natriuretic factor in the rabbit isolated vas deferens.J Pharmacol Exp Ther. 1994 Jan;268(1):117-23. J Pharmacol Exp Ther. 1994. PMID: 7507992
-
Paired pulse analysis of ATP and noradrenaline release from sympathetic nerves of rat tail artery and mouse vas deferens: effects of K+ channel blockers.Br J Pharmacol. 1998 Dec;125(8):1669-76. doi: 10.1038/sj.bjp.0702246. Br J Pharmacol. 1998. PMID: 9886758 Free PMC article.
-
Further examination of the inhibitory actions of alpha 1-adrenoceptor agonists in rat vas deferens.Eur J Pharmacol. 1985 Jul 17;113(2):239-45. doi: 10.1016/0014-2999(85)90741-1. Eur J Pharmacol. 1985. PMID: 2412843
-
Alpha1A-adrenoceptor mediated contraction of rat prostatic vas deferens and the involvement of ryanodine stores and Ca2+ influx stimulated by diacylglycerol and PKC.Br J Pharmacol. 1998 Jan;123(2):317-25. doi: 10.1038/sj.bjp.0701588. Br J Pharmacol. 1998. PMID: 9489621 Free PMC article.
Cited by
-
Neurotransmitter release mechanisms in sympathetic neurons: past, present, and future perspectives.Neurochem Res. 2001 Sep;26(8-9):875-89. doi: 10.1023/a:1012320130988. Neurochem Res. 2001. PMID: 11699939 Review.
-
Inhibition of neuroeffector transmission in human vas deferens by sildenafil.Br J Pharmacol. 2000 Nov;131(5):871-4. doi: 10.1038/sj.bjp.0703657. Br J Pharmacol. 2000. PMID: 11053205 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous